SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Enanta Pharmaceuticals (ENTA)

ENTA RSS Feed
Add ENTA Price Alert      Hide Sticky   Hide Intro
Moderator: DewDiligence
Search This Board: 
Last Post: 10/10/2017 11:17:37 AM - Followers: 62 - Board type: Free - Posts Today: 0
SureTrader
Interactive Brokers Advertisement
ENTA
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ENTA News: Enanta Announces Data to be Presented on AbbVie’s MAVYRET™ (glecaprevir/pibrentasvir) at The Liver Meeting® 2017 10/11/2017 03:03:00 PM
ENTA News: Enanta Pharmaceuticals Announces New Data Presentations on EDP-305, an FXR Agonist for NASH and PBC, at The Liver Meeting® 2... 09/27/2017 04:14:00 PM
ENTA News: Enanta Announces that AbbVie’s MAVIRET™ (glecaprevir/pibrentasvir) Received Approval in Japan for the Treatment of All Ma... 09/27/2017 06:30:00 AM
ENTA News: Statement of Changes in Beneficial Ownership (4) 09/13/2017 06:08:36 PM
ENTA News: Initial Statement of Beneficial Ownership (3) 09/13/2017 05:53:06 PM
PostSubject
#1483  Sticky Note FDA approves ABBV/ENTA’s Mavyret: #msg-133548596. DewDiligence 08/03/17 03:24:43 PM
#1516   (EDIT)You might be interested in AASLD abstract #205 willyw 10/10/17 11:17:37 AM
#1515   Mavyret scripts for week ending 9/29/17: #msg-135250104. DewDiligence 10/09/17 11:57:57 AM
#1514   FDA's Approval Of A Cheaper Drug For Hepatitis willyw 10/04/17 08:09:59 AM
#1513   Mavyret scripts for week ending 9/22/17: #msg-135002682. DewDiligence 09/29/17 10:15:55 AM
#1512   That's not Barron's per se—it's a sell-side note DewDiligence 09/28/17 02:53:16 PM
#1511   http://www.barrons.com/articles/gileads-china-entrance-looks-crowded-1506532587 willyw 09/28/17 02:28:15 PM
#1509   Many investors think that HCV is tapped out. DewDiligence 09/28/17 12:05:12 PM
#1508   The SA piece is assuredly wrong about Viekira DewDiligence 09/28/17 12:03:53 PM
#1507   Maviret in China? willyw 09/28/17 12:01:14 PM
#1506   ENTA’s AASLD presentations for EDP-305 (NASH/PBC): DewDiligence 09/27/17 04:24:00 PM
#1505   Japan approves Maviret, triggering $15M milestone payment: #msg-134935488. DewDiligence 09/27/17 09:44:02 AM
#1504   Mavyret scripts for week ending 9/18/17: #msg-134887306. DewDiligence 09/25/17 03:14:49 PM
#1503   New slide set from CF presentation today: DewDiligence 09/25/17 09:38:10 AM
#1502   Highest intraday and closing prices since Aug2015 (eom). DewDiligence 09/15/17 04:21:28 PM
#1501   Mavyret scripts for week ending 9/8/17 (from IMS)… DewDiligence 09/15/17 10:10:30 AM
#1500   Yes, I erroneously switched the numbers—will repost. Thanks DewDiligence 09/15/17 10:08:36 AM
#1499   Shouldn't Total be bigger than new? DaveAu 09/15/17 10:04:33 AM
#1497   RBC Capital initiates coverage on Enanta Pharmaceuticals (NASDAQ: Bickema 09/15/17 08:37:05 AM
#1496   Thank you Dew. Bickema 09/14/17 10:45:33 AM
#1495   Mavyret scripts for the week ending 9/1/17 were DewDiligence 09/14/17 10:42:46 AM
#1494   Dew or Anyone else seen any new script Bickema 09/14/17 10:39:36 AM
#1493   ENTA adds director—BoD size increased to 7: DewDiligence 09/13/17 08:58:07 AM
#1492   Very positive day... willyw 08/25/17 05:42:42 PM
#1491   Possibly, but Zacks isn't taken seriously by seasoned DewDiligence 08/25/17 02:04:05 PM
#1490   Or maybe this helped: JK2016 08/25/17 02:02:24 PM
#1489   ...weekly prescription counts may be where we see DewDiligence 08/25/17 01:45:08 PM
#1488   G/P Phase 3b trials; Sofosbuvir failures (in Genotype 1). willyw 08/23/17 11:36:20 AM
#1487   Maviret* approved in Canada: DewDiligence 08/18/17 11:01:07 AM
#1486   Pro forma cash, diluted share count, and enterprise DewDiligence 08/09/17 06:24:34 PM
#1485   ENTA FY3Q17 CC transcript: DewDiligence 08/08/17 10:40:19 AM
#1484   ENTA reports FY3Q17 results: DewDiligence 08/07/17 04:21:49 PM
#1483   FDA approves ABBV/ENTA’s Mavyret: #msg-133548596. DewDiligence 08/03/17 03:24:43 PM
#1482   European Commission approves GILD’s Vosevi and ABBV/ENTA’s Maviret, DewDiligence 07/28/17 12:14:38 PM
#1480   FY3Q17 CC 8/7/17, 4:30pm ET: DewDiligence 07/25/17 04:43:10 PM
#1479   Vosevi’s US list price leaves ample room for DewDiligence 07/19/17 11:10:25 AM
#1478   I don't have any company-specific explanation. Note that DewDiligence 07/10/17 12:15:21 PM
#1477   Anyone care to speculate why the stock is guyschmid 07/10/17 12:12:07 PM
#1476   News for 'ENTA' - (*DJ Enanta Announces New biotech_researcher 06/26/17 08:50:18 AM
#1475   ENTA will receive an undisclosed milestone payment from DewDiligence 06/23/17 09:44:23 AM
#1474   Sweet. I'll bet Dew didn't have the nifty DaveAu 06/23/17 08:57:06 AM
#1473   Enanta Announces that AbbVie Receives CHMP Positive Opinion DaveAu 06/23/17 08:54:44 AM
#1472   ENTA’s pro forma EV is only $412M: #msg-131344710. DewDiligence 05/14/17 01:18:19 PM
#1471   Early access to G/P in UK stockbettor 05/11/17 03:53:27 PM
#1470   ENTA reports FY2Q17 financial results: DewDiligence 05/08/17 04:09:48 PM
#1469   ENTA mentioned in Reuters profile of NASH arena: #msg-130744801. DewDiligence 04/24/17 10:40:29 AM
#1468   JNJ/ACHN’s 3-DAA HCV regimen has a problem: #msg-130712374. DewDiligence 04/22/17 11:59:23 AM
#1467   Brief comments on today's PR: #msg-130606473. DewDiligence 04/19/17 11:41:21 AM
#1466   Enanta Announces New Preclinical Data on its FXR biotech_researcher 04/19/17 07:56:45 AM
#1464   It's low volume at least, but the data biotech_researcher 04/05/17 03:49:27 PM
#1463   New info showing EDP-305 superiority to Ocaliva in DewDiligence 04/05/17 10:37:11 AM
PostSubject